{"cdcTestId":"2022-0072","testcaseName":"Dose # 1 PCV15 at age 18 months","vaccineGroup":"PCV","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on minimum interval from previous dose (catch-up)","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2021-04-19T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"VAXNEUVANCE","cvx":"215","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2022-12-14T00:00:00","recommendedDate":"2022-12-14T00:00:00","pastDueDate":"2022-12-14T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"VAXNEUVANCE","cvx":"215","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2022-09-15T09:19:25.392","generalDescription":"This test case describes when dose #1 of the PCV15 vaccine is administered at age 18 months that the dose is considered to be valid and the patient is on a catch-up schedule.","changedInVersion":"4.27","reasonForChange":""}